Outcomes of a nine-month regimen for rifampicin-resistant tuberculosis up to 24 months after treatment completion in nine African countries

Treatment outcomes of the shorter regimen for rifampicin-resistant tuberculosis are not completely established. We report on these outcomes two years after treatment completion among patients enrolled in an observational cohort study in nine African countries. 1,006 patients treated with the nine-mo...

Full description

Saved in:

Bibliographic Details
Published in:	EClinicalMedicine Vol. 20; p. 100268
Main Authors:	Schwœbel, Valérie, Trébucq, Arnaud, Kashongwe, Zacharie, Bakayoko, Alimata S., Kuaban, Christopher, Noeske, Juergen, Harouna, Souleymane H., Souleymane, Mahamadou B., Piubello, Alberto, Ciza, François, Fikouma, Valentin, Gasana, Michel, Ouedraogo, Martial, Gninafon, Martin, Van Deun, Armand, Tagliani, Elisa, Cirillo, Daniela M., Koura, Kobto G., Rieder, Hans L.
Format:	Journal Article
Language:	English
Published:	England Elsevier Ltd 01.03.2020 Elsevier
Subjects:	Cohort studies Developing countries Fluoroquinolones Internal Medicine Isoniazid Multidrug-resistance Proportional hazard models Recurrence Research paper Short regimen Treatment outcome Tuberculosis Fluoroquinolones Treatment outcome Recurrence Tuberculosis Short regimen Cohort studies Developing countries Proportional hazard models Isoniazid Multidrug-resistance
ISSN:	2589-5370, 2589-5370
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!